Ratto Elena, Leoncini Giovanna, Viazzi Francesca, Bezante Gian Paolo, Falqui Valeria, Parodi Angelica, Conti Novella, Tomolillo Cinzia, Deferrari Giacomo, Pontremoli Roberto
Department of Internal Medicine, University of Genoa, Genoa, Italy.
J Hypertens. 2008 Feb;26(2):345-50. doi: 10.1097/HJH.0b013e3282f2b149.
Inappropriate left ventricular mass (LVM) and microalbuminuria predict cardiovascular events in hypertension. We attempted to evaluate the relationship between inappropriate LVM and albuminuria in hypertensive patients.
Four hundred and two nondiabetic, untreated patients with primary hypertension were studied. The appropriateness of LVM to cardiac workload was calculated by the ratio of observed LVM to the predicted value using the reference equation. Albuminuria was evaluated by the urinary albumin to creatinine ratio.
The deviation of LVM from the predicted value was positively related to albuminuria (P < 0.0001). Multiple regression analysis showed that albuminuria (0.0182), pulse pressure (P < 0.0001) and left ventricular hypertrophy (LVH) (P < 0.0001) were the only independent predictors of observed/predicted LVM. When subjects were divided into subgroups on the basis of the presence/absence of inappropriate LVM, patients with inappropriate LVM showed higher urinary albumin excretion (P < 0.0001), regardless of potential confounding factors, including LVH (analysis of covariance, P = 0.0453), and higher prevalence of microalbuminuria (P = 0.0024) compared to those without it. Analogous results were obtained by looking at the study patients on the basis of the presence of micro- or normoalbuminuria. Indeed, patients with microalbuminuria showed higher prevalence of inappropriate LVH compared to other left ventricular geometries (appropriate LVH and absence of LVH) (P < 0.0001). After adjusting for confounders, microalbuminuria entailed a three- and five-fold greater risk of having appropriate and inappropriate LVH, respectively.
Inappropriate LVM is associated with albuminuria in hypertension. These data strengthen the role of microalbuminuria as an indicator of high cardiovascular risk.
左心室质量(LVM)异常和微量白蛋白尿可预测高血压患者的心血管事件。我们试图评估高血压患者中LVM异常与白蛋白尿之间的关系。
对402例未经治疗的非糖尿病原发性高血压患者进行研究。使用参考方程,通过观察到的LVM与预测值的比值来计算LVM与心脏工作负荷的适配性。通过尿白蛋白与肌酐比值评估白蛋白尿。
LVM与预测值的偏差与白蛋白尿呈正相关(P < 0.0001)。多元回归分析显示,白蛋白尿(0.0182)、脉压(P < 0.0001)和左心室肥厚(LVH)(P < 0.0001)是观察到的/预测的LVM的仅有的独立预测因素。当根据是否存在LVM异常将受试者分为亚组时,无论包括LVH在内的潜在混杂因素如何(协方差分析,P = 0.0453),LVM异常的患者尿白蛋白排泄均较高(P < 0.0001),且微量白蛋白尿的患病率高于无LVM异常的患者(P = 0.0024)。基于微量或正常白蛋白尿的存在情况对研究患者进行分析,也得到了类似结果。事实上,与其他左心室几何形态(适当LVH和无LVH)相比,微量白蛋白尿患者中不适当LVH的患病率更高(P < 0.0001)。在调整混杂因素后,微量白蛋白尿分别使发生适当和不适当LVH的风险增加3倍和5倍。
高血压患者中LVM异常与白蛋白尿相关。这些数据强化了微量白蛋白尿作为高心血管风险指标的作用。